Corpus Intelligence IC Memo — KFH-HAWAII 2026-04-26 09:33 UTC
IC Memo — KFH-HAWAII
Investment Committee Memorandum | HI | 285 beds | Grade C | EBITDA uplift $27.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KFH-HAWAII

CCN 120011 | HONOLULU, HI | 285 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KFH-HAWAII is a 285-bed suburban community hospital in HONOLULU, HI with $377.3M in net patient revenue and a -13.8% operating margin. The hospital serves a payer mix of 4.0% Medicare, 0.2% Medicaid, and 95.8% commercial.

Thesis: Undervalued. Our ML models identify $27.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.8% to -6.5% (+736bps).

Net Revenue HCRIS$377.3M
Current EBITDA COMPUTED$-52.2M
Operating Margin COMPUTED-13.8%
Occupancy HCRIS52.3%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS31.1%
Distress Probability ML46.2%

2. Market Context & Competitive Position

26
HI Hospitals
-14.7%
State Median Margin
1554
Comparable Hospitals

HI has 26 Medicare-certified hospitals with a median operating margin of -14.7%. The target's margin of -13.8% places it above the state median. Among 1554 size-comparable peers (142-570 beds), the median margin is -3.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (142-570), prioritizing same-state peers. 1554 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KFH-HAWAII (Target)HI285$377.3M-13.8%
MEMORIAL HOSPITAL FOR CANCER ANY514$4.34B-32.5%
RONALD REAGAN UCLACA446$2.62B-6.8%
OHSU HOSPITAL AND CLINICSOR549$2.57B-6.3%
LUCILE PACKARD CHILDRENS HOSPICA394$2.39B-0.8%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
MAYO CLINIC HOSPITALAZ315$2.25B1.4%
RAINBOW BABIES & CHILDRENS HOSOH231$2.22B-5.0%
EASTERN MAINE MEDICAL CENTERME352$2.05B48.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $27.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.9M+210bp18mo
Cost to Collect4.5%2.5%$7.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.6M+122bp9mo
Clean Claim Rate88.0%96.0%$241K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.9M
Cost to Collect
$7.5M
Denial Rate Reduction
$7.5M
A/R Days Reduction
$4.6M
Clean Claim Rate
$241K
Total EBITDA Uplift$27.8M
Current EBITDA$-52.2M
+ RCM Uplift+$27.8M
Pro Forma EBITDA$-24.4M
Current Margin-13.8%
Pro Forma Margin-6.5%
WC Released (1x)$14.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-80.2M$-66.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-80.2M$-99.0M0.00x-100.0%
Bull Case9.0x11.0x$-72.2M$-33.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-72.2M$-57.8M0.00x-100.0%
Bear Case11.0x10.0x$-88.3M$-179.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-88.3M$-225.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 1554 hospitals with 142-570 beds
  • Same-state prioritization (n=7)
  • Comp margins: P25=-13.3% / P50=-3.9% / P75=5.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.